Vascular Leaders Forum

VLF_LOGO  IMG_4543

Thursday, April 14 - Friday, April 15, 2016

Washington, D.C.

    Vascular Leaders Forum (VLF) is the first unique, multidisciplinary think-tank style meeting of the clinical thought leaders in the field, regulatory and reimbursement policy experts from the US federal government and industry representatives focused on advancing the future of vascular disease care. VLF is specifically focused on the global management of critical limb ischemia, one of the most challenging patient disorders we face. This 1 ½ day forum will critically distill the current state, deficiencies, unmet needs (clinical, operational and research) and future opportunities in the treatment of CLI. The goal of this conference is to develop a reference standard, or “blueprint” for advancing the field. Meeting content will be available soon, please check back.

AGENDA

Introduction, Review of Scope and Goals  Michael R. Jaff, DO
What is a CLI Clinical “Team” in the era of Accountable Care, What are the Key Elements Required for Success, and Why do we Need Them? Chris White, MD
CLI Clinical and Endpoint Based Risk Stratification: Creating a Scoring System for CLI Patients?  John Rundback, MD
BREAKOUT SESSION #1 DISCUSSION GROUP #1: CLI Teams: Identifying Key Capabilities for Improved Outcomes: A Specialty Agnostic Approach Co-Moderators: Gary Ansel, MD; Ken Rosenfield, MD DISCUSSION GROUP #2: CLI Risk Score: Impact of Clinical Prediction and Endpoint Analysis Co-Moderators: Tony Das, MD; John Rundback, MD
BREAKOUT SESSION #2 DISCUSSION GROUP #2: CLI Teams: Identifying Key Capabilities for Improved Outcomes: A Specialty Agnostic Approach Co-Moderators: Gary Ansel, MD; Ken Rosenfield, MD DISCUSSION GROUP #1: CLI Risk Score: Impact of Clinical Prediction and Endpoint Analysis Co-Moderators: Tony Das, MD; John Rundback, MD
Special Governmental Session: FDA/CMS Identifying Unmet Needs and Barriers to Advancement in CLI in 2016 Co-Moderators: Michael R. Jaff, DO; Krishna Rocha-Singh, MD; Peter Schneider, MD
Full Faculty Discussion: Summary of Breakout Groups and FDA /CMS Session Co-Moderators: Gary Ansel, MD; John Rundback, MD
Opening Remarks and Update on Key Take Home Points from Day 1 Tony Das, MD
Challenges to Management of Chronic Diseases (i.e. CLI) in the Current Healthcare Climate Michael Guiry, PA-C, MBA
How Do We Develop and Adopt New Therapies? Misti Malone, PhD
WRITING GROUPS BREAKOUT CLI Team Fundamentals Gary Ansel, MD; Ken Rosenfield, MD
Clinical Vascular Scoring System Tony Das, MD; John Rundback, MD

Photos